Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 6/20 | 0.38 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3323297 | 0.87 | SCD (0.38) | SCDSCD5FFAR1FFAR4PKM | |
| SCHEMBL3321685 | 0.80 | SCD (0.51) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3231480 | 0.77 | SCD (0.55) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3894169 | 0.74 | SCD (0.51) | SCDSCD5OXTR | |
| SCHEMBL3324764 | 0.73 | SCD (0.41) | SCDSCD5FFAR1FFAR4PKM | |
| SCHEMBL3263788 | 0.72 | SCD (0.66) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3322147 | 0.72 | SCD (0.36) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3232055 | 0.71 | SCD (0.47) | SCDSCD5 | |
| SCHEMBL3323446 | 0.71 | SIRT6 (0.43) | SCDSCD5FFAR1FFAR4PKM | |
| SCHEMBL3323243 | 0.69 | FFAR4 (0.40) | SCDSCD5FFAR1FFAR4PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120784-A1 | NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | MERCK FROSST CANADA LTD. (CA) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120784-A1 | NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | SCD, SCD5, ACSL6 | SCD 1/4885SCD5 2/4885FFAR1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.